Elsevier

The Journal of Nutrition

Volume 151, Issue 2, February 2021, Pages 281-292
The Journal of Nutrition

Genetic Risk Score for Serum 25-Hydroxyvitamin D Concentration Helps to Guide Personalized Vitamin D Supplementation in Healthy Finnish Adults

https://doi.org/10.1093/jn/nxaa391Get rights and content
Under an Elsevier user license
open archive

Background

Genetic factors modify serum 25-hydroxyvitamin D [25(OH)D] concentration and can affect the optimal intake of vitamin D.

Objectives

We aimed to personalize vitamin D supplementation by applying knowledge of genetic factors affecting serum 25(OH)D concentration.

Methods

We performed a genome-wide association study of serum 25(OH)D concentration in the Finnish Health 2011 cohort (n = 3339) using linear regression and applied the results to develop a population-matched genetic risk score (GRS) for serum 25(OH)D. This GRS was used to tailor vitamin D supplementation for 96 participants of a longitudinal Digital Health Revolution (DHR) Study. The GRS, serum 25(OH)D concentrations, and personalized supplementation and dietary advice were electronically returned to participants. Serum 25(OH)D concentrations were assessed using immunoassays and vitamin D intake using FFQs. In data analyses, cross-sectional and repeated-measures statistical tests and models were applied as described in detail elsewhere.

Results

GC vitamin D–binding protein and cytochrome P450 family 2 subfamily R polypeptide 1 genes showed genome-wide significant associations with serum 25(OH)D concentration. One single nucleotide polymorphism from each locus (rs4588 and rs10741657) was used to develop the GRS. After returning data to the DHR Study participants, daily vitamin D supplement users increased from 32.6% to 60.2% (P = 6.5 × 10−6) and serum 25(OH)D concentration from 64.4 ± 20.9 nmol/L to 68.5 ± 19.2 nmol/L (P = 0.006) between August and November. Notably, the difference in serum 25(OH)D concentrations between participants with no risk alleles and those with 3 or 4 risk alleles decreased from 20.7 nmol/L to 8.0 nmol/L (P = 0.0063).

Conclusions

We developed and applied a population-matched GRS to identify individuals genetically predisposed to low serum 25(OH)D concentration. We show how the electronic return of individual genetic risk, serum 25(OH)D concentrations, and factors affecting vitamin D status can be used to tailor vitamin D supplementation. This model could be applied to other populations and countries.

Keywords

vitamin D
genetic risk score
personalized nutrition
DHR Study
Health 2011 survey

Abbreviations

CYP2R1
cytochrome P450 family 2 subfamily R polypeptide 1
DHR
Digital Health Revolution
FIMM
Institute for Molecular Medicine Finland
GC
GC vitamin D–binding protein
GRS
genetic risk score
GWAS
genome-wide association study
H2011
Health 2011
HWE
Hardy–Weinberg equilibrium
S25(OH)D
serum 25-hydroxyvitamin D
SNP
single nucleotide polymorphism
THL
Finnish Institute for Health and Welfare
VDSP
Vitamin D Standardization Program
25(OH)D
25-hydroxyvitamin D.

Cited by (0)

This research was supported by a grant from Tekes (Business Finland)—the Finnish Funding Agency for Innovation—as part of the Digital Health Revolution (DHR) program. The research group led by OK was also supported by the Sigrid Jusélius Foundation, Academy of Finland, and Knut and Alice Wallenberg Foundation.

Author disclosures: JIK is a member of a speakers’ bureau (Pfizer, Orion, MSD) and of a scientific advisory board (Pfizer). Part of MAK's salary is covered by a large Finnish biobank study FinnGen, funded by 11 international pharmaceutical companies [Abbvie, AstraZeneca, Biogen, Celgene, Genentech (a member of the Roche Group), GSK, Janssen, MazeTherapeutics, Merck/MSD, Pfizer, and Sanofi]. OK is a cofounder and board member of bioinformatics startup Medisapiens, and cancer therapeutics company Sartar Therapeutics, and engaged in industrial collaborations with Astra-Zeneca, Takeda, and Pelago. All the other authors report no conflicts of interest.

Supplemental Tables 1–6 and Supplemental Figures 1–5 are available from the “Supplementary data” link in the online posting of the article and from the same link in the table of contents at http://academic.oup.com/jn.